CP
TAK icon

Covenant Partners’s Takeda Pharmaceutical TAK Stock Holding History

Covenant Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,340
Closed -$394K – 197
2024
Q1 		$394K Buy
+28,340
New +$412K 0.11% 117
2023
Q4 		– Sell
-40,015
Closed -$619K – 198
2023
Q3 		$619K Sell
40,015
-368
-0.9% -$5.7K 0.22% 77
2023
Q2 		$634K Sell
40,383
-3,357
-8% -$55K 0.23% 71
2023
Q1 		$721K Sell
43,740
-2,362
-5% -$37.6K 0.28% 58
2022
Q4 		$719K Buy
46,102
+2,362
+5% +$33K 0.29% 59
2022
Q3 		$567K Sell
43,740
-4,722
-10% -$65.7K 0.28% 68
2022
Q2 		$680K Hold
48,462
– – 0.31% 66
2022
Q1 		$694K Buy
48,462
+4,722
+11% +$69.3K 0.28% 77
2021
Q4 		$596K Sell
43,740
-1,493
-3% -$20.9K 0.22% 99
2021
Q3 		$741K Buy
45,233
+19,572
+76% +$329K 0.29% 74
2021
Q2 		$432K Sell
25,661
-28,637
-53% -$487K 0.16% 131
2021
Q1 		$991K Sell
54,298
-7,385
-12% -$133K 0.39% 47
2020
Q4 		$1.12M Buy
61,683
+13,157
+27% +$231K 0.48% 39
2020
Q3 		$866K Sell
48,526
-4,873
-9% -$88.7K 0.42% 52
2020
Q2 		$957K Sell
53,399
-14,891
-22% -$267K 0.44% 44
2020
Q1 		$1.04M Sell
68,290
-2,957
-4% -$53.6K 0.55% 26
2019
Q4 		$1.41M Sell
71,247
-3,960
-5% -$75.8K 0.66% 24
2019
Q3 		$1.29M Buy
75,207
+11,724
+18% +$203K 0.69% 27
2019
Q2 		$1.12M Buy
63,483
+4,480
+8% +$81.5K 0.6% 33
2019
Q1 		$1.2M Buy
59,003
+5,492
+10% +$111K 0.67% 22
2018
Q4 		$900K Buy
+53,511
New +$903K 0.43% 17

Other funds holding TAK

GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Covenant Partners's TAK Position: Q2 2024 in Review

Covenant Partners sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 28,340 shares — an estimated $394K sold.

Covenant Partners first reported a position in TAK in Q4 2018 and held it in 21 quarters. The position peaked at $1.41M in Q4 2019. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

  • Covenant Partners reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Covenant Partners sold 28,340 Takeda Pharmaceutical shares in Q2 2024, an estimated $394K.
  • Covenant Partners first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 21 quarters.
  • Covenant Partners's Takeda Pharmaceutical position peaked at $1.41M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Covenant Partners's 13F filing for Q2 2024, filed 5 Aug 2024.